Acorah Software Products - Accounts Production 16.7.461 false true false 30 March 2024 29 September 2025 29 September 2025 15606122 Mr Richard Busby Mr Edwin Fanshawe iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15606122 2024-03-29 15606122 2025-09-29 15606122 2024-03-30 2025-09-29 15606122 frs-core:CurrentFinancialInstruments 2025-09-29 15606122 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-09-29 15606122 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-30 2025-09-29 15606122 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-29 15606122 frs-core:ShareCapital 2025-09-29 15606122 frs-core:RetainedEarningsAccumulatedLosses 2025-09-29 15606122 frs-bus:PrivateLimitedCompanyLtd 2024-03-30 2025-09-29 15606122 frs-bus:FilletedAccounts 2024-03-30 2025-09-29 15606122 frs-bus:SmallEntities 2024-03-30 2025-09-29 15606122 frs-bus:AuditExempt-NoAccountantsReport 2024-03-30 2025-09-29 15606122 frs-bus:SmallCompaniesRegimeForAccounts 2024-03-30 2025-09-29 15606122 frs-bus:Director1 2024-03-30 2025-09-29 15606122 frs-bus:Director2 2024-03-30 2025-09-29 15606122 frs-countries:EnglandWales 2024-03-30 2025-09-29
Registered number: 15606122
MXAI Health Limited
Unaudited Financial Statements
For the Period 30 March 2024 to 29 September 2025
Seagrave French
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 15606122
29 September 2025
Notes £ £
FIXED ASSETS
Intangible Assets 4 29,806
29,806
CURRENT ASSETS
Debtors 5 5,085
Cash at bank and in hand 964
6,049
Creditors: Amounts Falling Due Within One Year 6 (3,754 )
NET CURRENT ASSETS (LIABILITIES) 2,295
TOTAL ASSETS LESS CURRENT LIABILITIES 32,101
NET ASSETS 32,101
CAPITAL AND RESERVES
Called up share capital 7 40,000
Profit and Loss Account (7,899 )
SHAREHOLDERS' FUNDS 32,101
For the period ending 29 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Richard Busby
Director
11/12/2025
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
MXAI Health Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15606122 . The registered office is 1 Brebners Accountants, 1 Suffolk Way, Sevenoaks, Kent, TN13 1YL.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Research and Development
In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research is recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised over 25 years on a straight line basis which is their expected useful economic life.
If it is not possible to distinguish between the research phase and the development phase of an internal project the expenditure is treated as if it were all incurred in the research phase only.
3. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
4. Intangible Assets
Development Costs
£
Cost
As at 30 March 2024 -
Additions 31,048
As at 29 September 2025 31,048
Amortisation
As at 30 March 2024 -
Provided during the period 1,242
As at 29 September 2025 1,242
Net Book Value
As at 29 September 2025 29,806
As at 30 March 2024 -
5. Debtors
29 September 2025
£
Due within one year
Other debtors 5,085
Page 2
Page 3
6. Creditors: Amounts Falling Due Within One Year
29 September 2025
£
Trade creditors 3,754
7. Share Capital
29 September 2025
£
Allotted, Called up and fully paid 40,000
Page 3